Icon banks on translational medicine with U.K. expansion

Icon ($ICLR) is expanding its capacity in the U.K., plotting to set up a 40,000-square-foot translational medicine operation within the Manchester Royal Infirmary Campus' Citylabs. Icon is banking on a boom in translational medicine demand as drug developers seek to understand the relationship between drug exposure and response. Release

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

Analytica Laser has a novel system which the company touts as the industry's first dynamic tool to predict real-world health outcomes.